Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyotrophic lateral sclerosis
Biotech
Ferrer offers $122M biobucks for ex-US license to Verge ALS drug
Spanish pharma Ferrer is following in Big Pharma’s footsteps by targeting the AI-powered neuroscience R&D work of Verge Genomics.
James Waldron
Mar 25, 2024 8:16am
Seelos' sugar therapy fails to improve ALS severity in ph. 2/3
Mar 19, 2024 10:00am
Amid pivot, Denali Therapeutics sends staff packing
Feb 26, 2024 12:22pm
Sanofi stumbles in HIMALAYA trial, chalking up phase 2 ALS fail
Feb 20, 2024 4:40am
Athira's ALS drug boosts survival, slows motor decline in mice
Feb 12, 2024 1:35am
Dewpoint trims headcount, pipeline to take condensates to clinic
Jan 17, 2024 11:10am